Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female
Interventions: DRUG: MW05|DRUG: PEG-rhG-CSF
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.